Sandra Rodríguez Coma/LinkedIn
Jul 18, 2026, 21:04
Sandra Rodríguez Coma: A Great Experience With the Werfen Team at ISTH 2026
Sandra Rodríguez Coma, Clinical Studies Scientist II at Werfen, shared a post on LinkedIn:
“Grateful for the opportunity to attend International Society on Thrombosis and Haemostasis (ISTH) 2026 in Paris together with my colleagues from Werfen.
It has been a very interesting and enriching congress, with valuable scientific sessions and great opportunities to learn, exchange ideas, and stay updated on the latest advances in thrombosis and hemostasis.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Aug 11, 2026, 16:44The Evolving Treatment Landscape of Hemophilia: From Factor Replacement to Gene Therapy
-
Aug 11, 2026, 16:34Advancing Hemophilia Care Through Training and Local Capacity Building – WFH
-
Aug 11, 2026, 16:26Sabrina H.: The Spectrum of PF4-Mediated Thrombotic Disorders
-
Aug 11, 2026, 16:17Mandy Lauw: From CRTH Training to Clinical Trials
-
Aug 11, 2026, 16:05Obi Light Ogbonnia: From 52 Years of Living With Sickle Cell to a Global Stage
-
Aug 11, 2026, 15:42Iva Pruner: Hemostasis, Thrombosis, and a Little Death Metal
-
Aug 11, 2026, 15:25Bradley Maron։ The AI Revolution in Cardiovascular Drug Development
-
Aug 11, 2026, 15:10Jared Rice: When a Negative DAT Doesn’t Mean the Alloimmune Risk Is Gone
-
Aug 11, 2026, 14:58Manuel De Jesus: Validating the Future of Point-of-Care Anemia Monitoring